Health Catalyst (NASDAQ:HCAT) Stock: Insider Benjamin Landry Sells 70,000 Shares

Health Catalyst, Inc. (NASDAQ:HCAT) General Counsel Benjamin Landry sold 70,000 shares of the business’s stock in a transaction dated Wednesday, November 11th. The shares were sold at an average price of $1.43, for a total transaction of $100,100.00. Following the completion of the sale, the general counsel directly owned 281,372 shares of the company’s stock, valued at $402,361.96. This represents a 19.92% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Benjamin Landry also recently made the following trade(s):

• On Thursday, November 12th, Benjamin Landry sold 29,478 shares of Health Catalyst stock. The stock was sold at an average price of $1.39, for a total transaction of $40,974.42.

Health Catalyst Stock Up 11.0%

Shares of HCAT traded up $0.15 during mid-day trading on Friday, hitting $1.51. 465,291 shares of the company’s stock were exchanged, compared to its average volume of 348,183. Health Catalyst, Inc. has a 52 week low of $0.96 and a 52 week high of $3.02. The stock’s 50-day simple moving average is $1.69 and its 200-day simple moving average is $1.68. The firm has a market cap of $114.99 million, a price-to-earnings ratio of -0.53 and a beta of 1.52.

Health Catalyst (NASDAQ:HCAT) last issued its quarterly earnings results on Thursday, November 5th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.02. The business had revenue of $56.28 million during the quarter, compared to analysts’ expectations of $55.39 million. Health Catalyst had a negative return on equity of 4.84% and a negative net margin of 74.24%. Analysts forecast that Health Catalyst, Inc. will post -0.18 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on HCAT. Wells Fargo & Company cut their target price on Health Catalyst from $1.75 to $1.50 and set an “equal weight” rating for the company in a research report on Thursday, August 13th. Weiss Ratings restated a “sell (d-)” rating on shares of Health Catalyst in a research report on Monday, October 26th. Citigroup dropped their price target on Health Catalyst from $2.50 to $2.00 and set a “neutral” rating for the company in a research note on Tuesday, August 11th. Finally, Canaccord Genuity Group cut shares of Health Catalyst from a “buy” rating to a “hold” rating and cut their price objective for the stock from $3.00 to $1.80 in a research report on Thursday, August 20th. Five equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Health Catalyst has a consensus rating of “Reduce” and a consensus price target of $2.01.

Institutional Trading of Health Catalyst

Institutional investors and hedge funds have recently modified their holdings of the business. BlackRock Inc. bought a new position in shares of Health Catalyst in the second quarter worth about $3,654,000. Hsbc Holdings PLC boosted its stake in shares of Health Catalyst by 313.3% in the 2nd quarter. Hsbc Holdings PLC now owns 408,634 shares of the company’s stock valued at $809,000 after purchasing an additional 309,766 shares in the last quarter. Palogic Value Management L.P. acquired a new stake in shares of Health Catalyst in the 2nd quarter valued at approximately $9,796,000. Squarepoint Ops LLC boosted its stake in shares of Health Catalyst by 1,214.8% in the 2nd quarter. Squarepoint Ops LLC now owns 400,210 shares of the company’s stock valued at $796,000 after purchasing an additional 369,772 shares in the last quarter. Finally, Headlands Technologies LLC bought a new stake in shares of Health Catalyst during the 2nd quarter valued at approximately $131,000. 85.00% of the stock is currently owned by institutional investors.

Health Catalyst Company Profile

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its solutions are designed to help providers use clinical, operational, and financial data to support decision-making and improve care delivery. The company’s offerings include a data platform that brings together information from multiple sources, analytics applications for healthcare workflows, and professional services. These services can include implementation, data management, and support for organizations developing and applying analytics programs.